CLINICAL_TRIALS
trial_result
· 2018-04-27
Clinical Trial Update: A Study of Pediatric Participants With Attention Deficit/Hyperactivity Disorder [Phase 2, Phase 3]
Summary
Phase 2/3 pediatric ADHD trial terminated; results posted previously.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Eli Lilly and Company | Conditions: Attention Deficit Hyperactivity Disorder | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2018-04-27